Company Profile

Bicycle Therapeutics (NASDAQ: BCYC)
9:00 PM UTC, 01/07/25
Last: $15.14 Change: +0.26 %Change: +1.75% Volume: 240,440
Detailed Quote
Open: $ 14.99   Volume: 240,440
High: $ 15.47   Yield(%) 0.00
Low: $ 14.87   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 1.03B
EPS ($) -3.30   Shares Out: 69.02M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -29.31
% Price Change (last 13 weeks): -36.41
% Price Change (last 26 weeks): -26.45
% Price Change (last 52 weeks): -21.27
% Price Change (year to date): 6.29
Management Effectiveness
Return on Equity (%): -56.52
Return on Assets (%): -36.06
Return on Invested Capital (%): -39.83
Profitability
Gross Profit Margin (%): 75.73
Net Profit Margin (%): -669.72
Operating Profit Margin (%): -796.30
Price & Volume
50-day Moving Average: $19.58
200-day Moving Average: $22.28
Avg. Daily Vol. (last 50 days): 624,249
Avg. Daily Vol. (last 200 days): 419,078
52-wk high: $28.67
52-wk low: $12.17
Bid: $14.12
Ask: $16.45
Company Information
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Bicycle Therapeutics
Granta Park Great Abington Portway Building Blocks A & B
Cambridge CA CB21 6GS

Phone: 44.1223.261503
Fax: n/a
http://bicycletherapeutics.com
Per Share Data
Earnings (1year) ($): -3.30
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 8.74
Cash Flow ($): -4.12
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 23.76
Price/Book (x): 2.07
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 8.08
Current Ratio (x): 8.08
LT Debt/Equity (x): 10.81
Total Debt/Equity (x): 12.12



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.